Brazil gets 40% cut on AIDS drugs

[Brad DeLong]

>Should we tax pharmaceutical companies? Should we subsidize them by
>doing most of the research and then handing over the property rights
>after members of Congress take campaign contributions?
>
>Ian

It seems pretty clear to me that on net we should be subsidizing 
pharmaceuticals. There are some amazing drugs out there. The NIH is 
very, very good at doing basic research. But there is no reason to 
think that a publicly-funded bureaucracy is particularly good at the 
process of drug development.

How to subsidize pharmaceuticals is a genuinely hard question...

Brad DeLong